Puma Biotechnology
PBYI
PBYI
137 hedge funds and large institutions have $1.69B invested in Puma Biotechnology in 2014 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 53 increasing their positions, 39 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 32
36% less capital invested
Capital invested by funds: $2.61B → $1.69B (-$928M)
Holders
137
Holding in Top 10
2
Calls
$48.3M
Puts
$24.4M
Top Buyers
| 1 | +$30.3M | |
| 2 | +$22.2M | |
| 3 | +$19.7M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$16.8M |
| 5 |
O
OrbiMed
New York
|
+$14.4M |
Top Sellers
| 1 | -$51.1M | |
| 2 | -$49M | |
| 3 | -$19.4M | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$17.9M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$17.2M |